Nora Nseir

Nora Nseir has extensive work experience in the medical device industry and health technology sector. Nora is the Inventor, Co-founder, Board of Directors, and Chief Technology Officer at Nurami Medical since April 2014. Nurami Medical is a company that focuses on proprietary nanofiber and sealant technology for the soft tissue repair market. Nora has also been a Member at 8400 The Health Network since January 2022 and at WE@HealthTech since January 2020. In 2013, Nora worked as a Development Project Leader at Technion in cooperation with Bonus Biogroup, Israel. Prior to that, they were an R&D Engineer at the Nano-engineering group, Technion in cooperation with BiolineRX, Israel from February 2012 to May 2013. Nora also has teaching and laboratory assistant experience at Technion - Israel Institute of Technology from January 2010 to March 2013.

Nora Nseir has a strong educational background with several degrees and certifications. Nora obtained a Bachelor of Science (BSc) in Biomedical/Medical Engineering from Technion - Israel Institute of Technology in 2009. Following this, they pursued a Master of Science (MSc) in Biomedical/Medical Engineering from the same institution from 2009 to 2011.

In terms of additional certifications, Nora completed a one-day course on Pharma-Biotech Product & Company Valuation with Dr. Patrik Frei, offered by CELforPharma in November 2021.

Nora has also engaged in several short-term educational programs and courses to enhance their skill set. In 2017, they participated in a Product Management course at StarVision - Product Experts. In 2015, they attended the Directors and Other Senior Corporate Officeholders course at Tel Aviv University - Coller School of Management. Additionally, Nora completed the TapasMBA program, an international mini MBA program, at Microsoft Ventures Academy in 2015. Prior to that, in 2013, they took a Medical Device Development course offered by Technion - Continuing Education.

Overall, Nora Nseir's education history showcases their dedication to continuous learning and their expertise in both biomedical/medical engineering and management/product development.